IXICO has reported its interim results for the six-months to March 2023, which are in-line with the recent trading update. Revenues for the period were £3.2m and the EBITDA loss was £0.6m. Cash at period end was £5.0m, the order book stood at £13.3m and the company generated operating cash inflows of £0.2m. Importantly, this period sees the final negative impact of the large trial cessations (2021/22), such that revenues are expected to grow from this point, in both H2/23E versus H1/23A and into ....
23 May 2023
Cenkos: IXICO Plc -- Successful execution
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Cenkos: IXICO Plc -- Successful execution
IXICO Plc (IXI:LON) | 8.8 0 0.0% | Mkt Cap: 4.23m
- Published:
23 May 2023 -
Author:
Chris Donnellan -
Pages:
10
IXICO has reported its interim results for the six-months to March 2023, which are in-line with the recent trading update. Revenues for the period were £3.2m and the EBITDA loss was £0.6m. Cash at period end was £5.0m, the order book stood at £13.3m and the company generated operating cash inflows of £0.2m. Importantly, this period sees the final negative impact of the large trial cessations (2021/22), such that revenues are expected to grow from this point, in both H2/23E versus H1/23A and into ....